Eterna Therapeutics (ERNA) - Prospectus(update)

As filed with the Securities and Exchange Commission on February 3, 2026. Registration No. 333-293150 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 TO FORM S-1 (State or other jurisdiction of incorporation or organization) Delaware 2834 31-1103425 (Primary Standard Industrial Classification Code Number) (Address, including zip code and telephone number, including area code, of registrant's principal executive offices) Sanjeev Luther President and Chief Executive Off ...